Moxibustion for cephalic version: a feasibility randomised controlled trial

BMC Complementary and Alternative Medicine

Research Article

Caroline A Smith¹  Hannah Dahlen²  Andrew Bisits³  Carole K Do⁴  Virginia Schmied⁵ 

[1] Centre for Complementary Medicine Research, University of Western Sydney, Locked Bag 1797, 2751, Penrith South DC, NSW, Australia;Family and Community Health Group, School of Nursing and Midwifery, University of Western Sydney, Locked Bag 1797, 2751, Penrith South DC, NSW, Australia;Royal Women's Hospital, Sydney, Australia;School of Biomedical and Health Sciences, University of Western Sydney, Locked Bag 1797, 2751, Penrith South DC, NSW, Australia;School of Nursing and Midwifery, University of Western Sydney, Locked Bag 1797, 2751, Penrith South DC, NSW, Australia;

关键词: breech;    moxibustion;    randomised controlled trial;    feasibility;   

DOI  :  10.1186/1472-6882-11-81

 received in 2011-06-21, accepted in 2011-09-26,  发布年份 2011

来源: Springer

【 摘 要 】

BackgroundMoxibustion (a type of Chinese medicine which involves burning a herb close to the skin) has been used to correct a breech presentation. Evidence of effectiveness and safety from systematic reviews is encouraging although significant heterogeneity has been found among trials. We assessed the feasibility of conducting a randomised controlled trial of moxibustion plus usual care compared with usual care to promote cephalic version in women with a breech presentation, and examined the views of women and health care providers towards implementing a trial within an Australian context.MethodsThe study was undertaken at a public hospital in Newcastle, New South Wales, Australia. Women at 34-36.5 weeks of gestation with a singleton breech presentation (confirmed by ultrasound), were randomised to moxibustion plus usual care or usual care alone. The intervention was administered over 10 days. Clinical outcomes included cephalic presentation at birth, the need for ECV, mode of birth; perinatal morbidity and mortality, and maternal complications. Feasibility outcomes included: recruitment rate, acceptability, compliance and a sample size for a future study. Interviews were conducted with 19 midwives and obstetricians to examine the acceptability of moxibustion, and views on the trial.ResultsTwenty women were randomised to the trial. Fifty one percent of women approached accepted randomisation to the trial. A trend towards an increase in cephalic version at delivery (RR 5.0; 95% CI 0.7-35.5) was found for women receiving moxibustion compared with usual care. There was also a trend towards greater success with version following ECV. Two babies were admitted to the neonatal unit from the moxibustion group. Compliance with the moxibustion protocol was acceptable with no reported side effects. Clinicians expressed the need for research to establish the safety and efficacy of moxibustion, and support for the intervention was given to increase women's choices, and explore opportunities to normalise birth. The sample size for a future trial is estimated to be 381 women.ConclusionOur findings should be interpreted with caution as the study was underpowered to detect statistical differences between groups. Acceptance by women and health professionals towards moxibustion suggest further research is warranted.Trial RegistrationAustralia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12609000985280

【 授权许可】

Unknown   
© Do et al; licensee BioMed Central Ltd. 2011. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.